BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2020
View Archived Issues
Recruitment of miR-8080 by luteolin as new therapeutic strategy in CRPC
Read More
Pancreatitis protein promotes pain
Read More
Rett gene affects maternal behavior via cortical plasticity
Read More
Norepinephrine is "unexpected connection" between amyloid and tau
Read More
BioTheryX initiates dosing in first-in-human phase I study of BTX-A51
Read More
LAM-002 shows antitumor activity in clinical setting and is to be evaluated as treatment of ALS
Read More
Medshine Discovery identifies isocitrate dehydrogenase mutant inhibitors
Read More
New liver X receptor alpha and beta inverse agonists discovered at Phenex-FXR
Read More
Roche, ETHZ disclose new cannabinoid CB2 receptor ligands
Read More
Adenosine A2A receptor antagonists identified at Zhejiang Vimgreen Pharma
Read More
ViiV Healthcare UK patents HIV integrase inhibitors
Read More
CADM1v8/9 variant useful to detect SCLC
Read More
Oncogenic FHL2-GLI2 fusion identified in sclerosing stromal tumors of the ovary
Read More
Evidence of activity seen in phase I trial of RMC-4630 in KRAS-mutant non-small cell lung cancer
Read More
Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy
Read More
Two new combination substudies evaluate pembrolizumab for NSCLC
Read More
PGAM1 inhibitor HKB-99 reduces non-small cell lung cancer tumor growth in vivo
Read More
Researchers discover compound with potential for EZH2-driven cancers
Read More
FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease
Read More
Amgen studies AMG-199 in patients with MUC17-positive gastric and GEJ cancer
Read More
Clene opens phase II study of CNM-Au8 in ALS
Read More